新型2,3-二氢-3-芳亚甲基-4-芳基-1,5-苯并硫氮杂革的合成及表征

在盐酸和乙醇存在下,苯乙酮、多聚甲醛以及N,N-二甲基甲酰胺进行Mannich反应,得到了Mannich碱;将其和1,2,4-三唑在水中反应,得到含有1,2,4-三唑的苯丙酮;然后,在哌啶和甲苯存在下,苯丙酮和苯甲醛进行羟醛缩合,得到一系列含有1,2,4-三氮唑的查尔酮;最后,在三氟乙酸的催化下,查尔酮和邻氨基硫酚发生亲核取代反应,然后脱水缩合,合成了一系列2,3-二氢-3-芳亚甲基-4-芳基-1,5-苯并硫氮杂革.其结构经IR,1H NMR,MS及元素分析确证.     

型2,3-二氢-3-芳亚甲基-4-芳基-1,5-苯并硫氮杂的合成及表征

在盐酸和乙醇存在下, 苯乙酮、多聚甲醛以及N,N-二甲基甲酰胺进行Mannich反应, 得到了Mannich碱; 将其和1,2,4-三唑在水中反应, 得到含有1,2,4-三唑的苯丙酮; 然后, 在哌啶和甲苯存在下, 苯丙酮和苯甲醛进行羟醛缩合, 得到一系列含有1,2,4-三氮唑的查尔酮; 最后, 在三氟乙酸的催化下, 查尔酮和邻氨基硫酚发生亲核取代反应, 然后脱水缩合, 合成了一系列2,3-二氢-3-芳亚甲基-4-芳基-1,5-苯并硫氮杂. 其结构经IR, ¹H NMR, MS及元素分析确证.     

含吡唑基的1,5-苯并硫氮杂衍生物的合成及晶体结构

以1-苯基-3-甲基-5-苯氧基-吡唑-4-甲醛和1-苯基-3-甲基-5-对甲苯氧基-吡唑-4-甲醛为原料, 在碱性条件下与苯乙酮(取代苯乙酮)发生羟醛缩合, 合成出10种新型含吡唑基的查尔酮; 再用此查尔酮与邻氨基硫酚在冰醋酸中反应, 合成了10种新的1,5-苯并硫氮杂, 化合物的结构经元素分析、IR和1H NMR确认, 同时测定了化合物6c的晶体结构. 化合物6c属单斜晶系(Monoclinic), 空间群P2(1)/n, 晶胞参数a=1.1793(2) nm, b=1.1907(2) nm, c=1.8726(4) nm, α=90°, β=104.71(3)°, γ=90°, M=522.04, V=2.5432(9) nm3, Dc=1.363 Mg/m3, Z=4, F(000)=1088.     

含吡唑基的1,5-苯并硫氮杂衍生物的合成及晶体结构

以1-苯基-3-甲基-5-苯氧基-吡唑-4-甲醛和1-苯基-3-甲基-5-对甲苯氧基-吡唑-4-甲醛为原料,在碱性条件下与苯乙酮(取代苯乙酮)发生羟醛缩合,合成出10种新型含吡唑基的查尔酮;再用此查尔酮与邻氨基硫酚在冰醋酸中反应,合成了10种新的1,5-苯并硫氮杂,化合物的结构经元素分析、IR和1HNMR确认,同时测定了化合物6c的晶体结构.化合物6c属单斜晶系(Monoclinic),空间群P2(1)/n,晶胞参数a=1.1793(2)nm,b=1.1907(2)nm,c=1.8726(4)nm,α=90°,β=104.71(3)°,γ=90°,M=522.04,V=2.5432(9)nm3,D=1.363Mg/m3,Z=4,F(000)=1088.     

新型1,5-苯并硫氮衍生物的合成和晶体结构

以β-二甲胺基苯丙酮盐酸盐为原料, 经过羟醛缩合, 与邻氨基硫酚的环化, 最后与氯乙酰氯的[2＋2]环加成反应, 合成了8种未见文献报道的新化合物, 其结构经IR, 1H NMR和MS及元素分析确证. 利用单晶X射线衍射法测定了化合物4e的晶体结构.     

新型1,5-苯并硫氮(革)衍生物的合成和晶体结构

以β-二甲胺基苯丙酮盐酸盐为原料,经过羟醛缩合,与邻氨基硫酚的环化,最后与氯乙酰氯的[2+2]环加成反应,合成了8种未见文献报道的新化合物,其结构经IR,1H NMR和MS及元素分析确证.利用单晶x射线衍射法测定了化合物4e的晶体结构.     

1,5-苯并硫氮杂(艹卓)-β-内酰胺的合成及其副产物的研究

以3-(3S-叔丁氧基)丁二酰亚胺基乙酰氯作为烯酮的来源,和1,5-苯并硫氮杂(艹卓)反应合成了4个具有光学活性的新型1,5-苯并硫氮杂(艹卓)-β-内酰胺衍生物.通过1H NMR,IR,MS谱和元素分析对其结构进行了表征,在得到目标产物的同时还得到了该反应的另外两个副产物,并且通过单晶X射线衍射确定了这两个副产物的结构.     

新型三环系稠杂环[1,2,4]-三唑并[1,5-a][1]-苯并氮杂(艹卓)及[1,2,4]-三唑并[1,5-a]-喹啉的合成

α-四氢萘酮的乙氧羰基腙(1)经LTA氧化, 得到α-偶氮-α-乙酰氧基化合物2. 在AlCl3作用下, 化合物2脱去乙酰氧基产生重氮正离子中间体3, 再经与腈的1,3-偶极环加成、 [1,2]-迁移扩环、碱性水解和与苦味酸作用, 得到新型[1,2,4]-三唑并[1,5-a][1]苯并氮杂(艹卓)苦味酸盐6a～6c. 以2,3-二氢-1-茚酮为底物, 采用相同的合成路线, 合成了1,2,4-三唑并[1,5-a]-二氢喹啉苦味酸盐12a～12c.     

含1,2,4-三唑-5-硫酮席夫碱的新型1,2,4-三唑并[1,5-a]嘧啶衍生物的合成及生物活性研究

以2-苄硫基-5-甲基-7-羟基-1,2,4-三唑并[1,5-a]嘧啶为原料,经醚化、肼解、成盐、关环和席夫碱反应合成了20个新型的含1,2,4-三唑-5-硫酮席夫碱的1,2,4-三唑并[1,5-a]嘧啶类化合物,通过IR,1H NMR,MS和元素分析对所合成的化合物进行了结构表征.初步生物活性测试结果表明,部分化合物表现出一定的抑菌或较好的抗烟草花叶病毒(TMV)活性.在500μg/mL浓度下,化合物6b,6f和6p对TMV的抑制率分别为41%,43%和40%.     

1,5-苯并硫氮杂氯代β-内酰胺衍生物的合成、光谱及立体化学

苯并硫氮杂是一类具有重要生理活性的七元杂环化合物, 近年来, 通过亚胺双键(CN)的环加成反应向此类化合物分子中引入新的环系引起了人们的关注[1～4].     

微波促进下3-(2-苯并呋喃基)-4-氨基-5-巯基-1,2,4-三唑

微波辐射条件下, 首先由2-苯并呋喃甲酰肼依次与二硫化碳和水合肼反应合成3-(2-苯并呋喃基)-4-氨基-5-巯基- 1,2,4-三唑, 进一步在微波辐射条件下由4-氨基-5-巯基-1,2,4-三唑分别与芳甲酸/芳氧基乙酸、α-溴代苯乙酮及芳醛反应以较高产率制得了相应的1,2,4-三唑并[3,4-b]-1,3,4-噻二唑、1,2,4-三唑并[3,4-b]-1,3,4-噻二嗪及4-芳亚甲基亚胺基-5-巯基-1,2,4-三唑. 产物结构经IR, ¹H NMR, MS及元素分析进行了表征.     

2-(2,6-二烷氧基苯基)苯并呋喃衍生物的合成

以焦性没食子酸、4-羟基苯甲醛和酚为原料, 以邻碘代苯酚与苯乙炔衍生物的Sonogashira偶联及其连串化反应生成苯并呋喃环为关键步骤, 设计合成了一系列2-(2 ,6 -二烷氧基苯基)苯并呋喃衍生物, 并对产物进行了¹H NMR, ¹³C NMR, MS等表征.     

Synthesis and Antiproliferative Activity of Novel [1,2,4]Triazolo[1,5-a]pyrimidine-7-amine Derivatives

A series of novel N-anilino-2-substituted-5-methyl-[1,2,4]triazolo[1,5-a]pyrimidine-7-amine derivatives was prepared and evaluated for their in vitro antiproliferative activity against two cancer cell lines,Bel-7402 and HT-1080.Most of the compounds inhibited the cell proliferation at a low concentration.Seven compounds,VI5,VI7,VI10,and VI12―VI15,possessed marked antiproliferative activity superior to that of cisplatin.Of these seven initial hits,compound VI10 was the most active.     

Synthesis and Characterization of Some Novel Multisubstituted 6,7-Dihydro-5H-cyclopenta[b]pyridine Derivatives

In this study, we describe systematic preparation of a series of aryl-substituted pyridine derivatives. The 1,5-dicarbonyls (3a–i) were prepared in the solvent-free conditions starting from chalcone derivatives (1a–i). The target compounds, 4-aryl-2-(thiophen-3-yl)-6,7-dihydro-5H-cyclopenta[b]-pyridine derivatives (5a–i), were synthesized by a cyclization reaction of the 1,5-dicarbonyls (3a–i) with ammonium acetate (NH₄OAc) in acetic acid. The characterization of synthesized compounds was proved by elemental analyses, infrared, mass spectrometry, and ¹H and ¹³C NMR spectroscopy.

[Supplementary materials are available for this article. Go to the publisher's online edition of Synthetic Communications® for the following free supplemental resource(s): Full experimental and spectral details.]     

Efficient Synthesis of 6-(1H-1,2,4-Triazol-1-yl)-thieno[2,3-d]pyrimidin-4(3H)-ones via an Iminophosphorane

Ethyl 2-amino-4-methyl-5-(1H-1,2,4-triazol-1-yl)thiophene-3-carboxylate 2, obtained from Gewald reaction of 1-(1H-1,2,4-triazol-1-yl)acetone 1 with ethyl cyanoacetate and sulfur, was transferred into iminophosphorane 3. Further reaction of 3 with aromatic isocyanates gave carbodiimides 4, which were treated subsequently with a secondary amine to give 6-(1H-1,2,4-triazol-1-yl)-thieno[2,3-d]pyrimidin-4(3H)-ones 6 in good yields in the presence of a catalytic amount of sodium ethoxide.     

新型2-氧代-1,2,4-三唑并[3,2-d][1,5]苯并氧氮杂类稠杂环的合成

将取代色满酮(1)与芳肼反应生成的腙与HNCO发生[3+2]环加成反应,加成产物(2)经氧化得到偕偶氮异氰酸酯(3).化合物3在HBF4的催化下发生环化-重排反应,得到新颖的三环系2-氧代-1,2,4-三唑并[3,2-d][1,5]苯并氧氮杂化合物5a～5g.     

Synthesis,Crystal Structure and Biological Activities of 1-（（5-（4-（4-Chlorophenoxy）-2-chlorophenyl）-2,2,3- trimethyloxazolidin-5-yl）methyl）-1H-1,2,4-triazole

The title compound 1-（（5-（4-（4-chlorophenoxy）-2-chlorophenyl）-2,2,3-trimethyl-oxazolidin- 5-yl）methyl）-lH-1,2,4-triazole （C21H22Cl2N4O2）has been synthesized and characterized by elemental analysis, IR, 1H NMR, MS and single-crystal X-ray diffraction. The crystal belongs to the triclinic system, space group Pi with a = 6.891（2）, b = 9.074（2）, c = 18.258（4）AA, α = 99.292（4）, β = 95.105（4）, γ = 108.068（3）°, C21H22Cl2N4O2, Mr = 433.33, V= 1059.3（4） Aa, Z = 2, Dc = 1.359 g/cm3, F（000） = 452,μ = 0.331 mm-1, the final R = 0.0448 and wR = 0.0994 for 3727 unique reflections. The dihedral angle between the oxazolidine ring taking an envelope conformation with a local pseudo-mirror and the triazole ring is 27.7（9）°. Weak intermolecular C-H...N hydrogen bonds and π-π interactions exist between the triazole rings of neighboring molecules, forming a three-dimensional network, which stabilizes the crystal structure. The primary biological test shows the target compound has certain fungicidal activity.     

Synthesis and Crystal Structure of Methyl(7,7-Dimethyl-2-amino-4-(4-chlorophenyl)-5-oxo-5,6,7,8-tetrahydro-4H-benzo-[b]-pyran-3-yl)Carboxylate

<正>The title compound methyl (7,7-dimemyl-2-amino-4-(4-chlorophenyl)-5-oxo-5,6,7,8-tetrahydro-4H-benzo-[b]-pyran-3-yl) carboxylate (C19H20ClNO4, Mr = 361.81) was synthesized and crystallized. The crystal belongs to triclinic, space group P 1 with a = 8.519(2), b = 10.346(2), c = 11.481(3) A, α = 108.16(1), β = 107.78(2), γ= 91.83(2)°, Z = 2, V = 906.5(3) A3, Dc = 1.326 g/cm3, μ(MoKα) = 0.234 mm-1, F(000) = 380, R = 0.0467 and wR = 0.1270 for 3142 observed reflections (I > 2σ(I)). X-ray analysis reveals that the C(7), C(8), C(9), O(1), C(10) and C(11) atoms form a six-membered ring which adopts a boat conformation. In the ring, the distances of C(8)-C(9) and C(10)-C(11) are 1.332(3) and 1.357(3) A, respectively, which indicates that they are C=C double bonds. Another six-membered ring (C(8)-C(9)-C(15)-C(14)-C(13)-C(12)) adopts the half-chair confonnation. In addition, there are intermolecular hydrogen bonds in the crystal structure.